Introduction: The 2-[18F]-Fluorodeoxyglucose (FDG) positron emission tomography
(PET/CT) has become an imaging tool for clinical assessment of tumor, node, metastasis in …

Data available in patients suffering from squamous cell carcinoma of the head and neck,
lung carcinoma, oesophageal carcinoma and gynaecological malignancies suggest that …

Purpose We conducted a comprehensive systematic review of the literature on volumetric
parameters from 18 F-FDG PET and a meta-analysis of the prognostic value of metabolic …

OBJECTIVE: To assess the prognostic value of metabolic tumor burden as measured with
metabolic tumor volume (MTV) and total lesion glycolysis (TLG) on 2-deoxy-2-(18F) fluoro-D …

Purpose We investigated whether the whole-body metabolic tumour volume (WBMTV)
measured by 18 F-fluorodeoxyglucose (FDG) positron emission tomography/computed …

We evaluated the ability of metabolic and volumetric parameters measured by pretreatment
18F-FDG PET/CT to predict the survival of patients with osteosarcoma of the extremities …

Despite the recent advances in lung cancer biology, molecular pathology, and treatment,
this malignancy remains the leading cause of cancer-related death worldwide and non …

Lung cancer remains a leading cause of cancerrelated deaths worldwide, accounting for
approximately 224,390 new patients and 158,080 deaths in 2016, according to the …

Purpose This study aimed to further stratify prognostic factors in patients with stage IV non-
small cell lung cancer (NSCLC) by measuring their metabolic tumor volume (MTV) using F …

Introduction Non-small cell lung cancer (NSCLC) patients with synchronous solitary
metastasis were generally considered as stage IV and believed to be incurable. Recently …